Search results
Better Health Care Newsletter - May 2024 | JD Supra
JD Supra· 4 days agoFederal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big...
Medicare Drug Price Negotiation; Diagnostic Errors
MedPage Today· 7 days agoTTHealthWatch is a weekly podcast from Texas Tech. This week's topics include Medicare negotiation on drugs and a loophole, neomycin for preventing...
How we can bridge the obesity-care gap for Black Americans
theGrio· 1 day agoToday, nearly 108 million American adults are living with obesity, and that number is expected to jump significantly, crossing the 50% threshold by 2030. While that statistic is undoubtedly ...
Medicare Posts $12B Loss for 2023 | ThinkAdvisor
ThinkAdvisor· 4 days agoThe post-pandemic surge in health care use, the aging U.S. population and health care worker shortages hit Medicare hard in 2023. Payroll tax revenue...
Fred L. Goldenberg: Medicare 2025 starting to bloom
Traverse City Record-Eagle· 5 days agoOver the last few weeks, I’ve been involved in several meetings, both in-person and online, regarding anticipated changes to Medicare and supplemental programs for 2025. According to the American ...
Q1 2024 Assertio Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoWe believe our market share in the clinic Medicare Part D market we currently serve is approximately 34%. Our success to date has been ...
HHS finalizes changes to Section 1557 regulations strengthening anti-discrimination protections | JD...
JD Supra· 3 days agoIn 2022, OCR and CMS issued a Notice of Proposed Rulemaking (NPRM) to reinterpret Section 1557 of the ACA, which prohibits discrimination on the basis of race, color, national origin, sex, age ...
Earnings call: Intra-Cellular reports robust growth in CAPLYTA sales
Investing.com· 4 days agoIntra-Cellular Therapies ( NASDAQ : NASDAQ: ITCI ) has announced a significant increase in revenues...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 6 days agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
Earnings call: Royalty Pharma reports robust growth and strategic acquisitions
Investing.com· 2 days agoRoyalty Pharma (RPRX) has reported a significant growth of 14% in Royalty Receipts, amounting to...
